Home »

RespireRx Pharmaceuticals Inc. Announces Participation SLEEP 2017 in Boston, MA

Senior Vice President of Research & Development to Present Poster Session on a Phase 2A Clinical Trial of CX1739 for the Prevention of Opioid Induced Respiratory Depression


© 2021 88Finance. All Rights Reserved. Log in

- Copyright by LayerMedia

Blogverzeichnis - Blog Verzeichnis bloggerei.de Blog Top Liste - by TopBlogs.de